Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...
Variational AI, a Vancouver-based Healthcare Tech Company, advances Generative AI Drug Discovery by designing novel small ...
Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...
VANCOUVER, British Columbia — Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply ...
3D printing has been making a big impact in the world of technology, providing a cost-effective and efficient way to manufacture a wide range of products. However, like any other technology, it still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results